Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.9%
5Y CAGR+14.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+24.9%/yr
vs +3.5%/yr prior
5Y CAGR
+14.8%/yr
Recent acceleration
Acceleration
+21.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $129.81M | +37.3% |
| 2024 | $94.52M | +17.6% |
| 2023 | $80.39M | +20.7% |
| 2022 | $66.59M | -3.4% |
| 2021 | $68.92M | +5.8% |
| 2020 | $65.16M | +3.2% |
| 2019 | $63.11M | +8.7% |
| 2018 | $58.04M | +14.0% |
| 2017 | $50.92M | +7.7% |
| 2016 | $47.30M | - |